Here's the latest info shared by WHO's Adriana Velázquez regarding Medical Devices and the World Health Organization (March 2020 Edition).
Dear colleagues, we are all facing very difficult times in the world with COVID pandemic. Here are Some extracts from the WHO media briefing:
“Funds will go towards actions outlined in the COVID-19 Strategic Preparedness and Response Plan to enable all countries – particularly those most vulnerable and at-risk, and with the weakest health systems – to prepare for and respond to the COVID-19 crisis including rapidly detecting cases, stopping transmission of the virus, and caring for those affected.
WHO and its partners are seeking financing for protective equipment for frontline health workers; to equip diagnostic laboratories; improve surveillance and data collection; establish and maintain intensive care units; strengthen supply chains; accelerate research and development of vaccines and therapeutics, and take other critical steps to scale up the public health response to the pandemic.
The COVID-19 Solidarity Response Fund is hosted by two foundations, the UN Foundation (registered in the United States) and the Swiss Philanthropy Foundation (registered in Switzerland). Both foundations have established relationships with the World Health Organization, allowing for efficient transfer of financial resources to enable COVID-19 response efforts.”
Last Friday 6th March, WHO news acknowledging the need for medical devices: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---6-march-2020
“….Separately, WHO has developed a list of more than 20 essential medical devices that countries need to manage patients, including ventilators and oxygen supply systems.
Access to medical oxygen could be the difference between life and death for some patients, but there is already a shortage in many countries, which could be exacerbated by this epidemic.
We encourage every country to review WHO’s disease commodity package for COVID-19 to ensure it has the supplies it needs, including protective equipment and medical devices.”
Please find below important information
1. Coronavirus 2019-nCov
1.1 Technical guidance: WHO is updating technical guidance every day, please find it here: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance
1.2 Disease commodity package, includes the tech specs of products needed for COVID. This list was just updated this week: https://www.who.int/publications-detail/disease-commodity-package---novel-coronavirus-(nCov)
1.3 Critical preparedness, readiness and response actions for COVID-19, updated this week: https://www.who.int/publications-detail/critical-preparedness-readiness-and-response-actions-for-covid-19
1.4 Daily Situation reports, that includes information from countries on existing and new cases, can be found: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
1.5 Research and Development, Blueprint and innovation: to accelerate vaccines, diagnostics, and therapeutics for Novel Coronavirus: https://www.who.int/blueprint/en/
WHO publishes Emergency Use Listing ( EUL) procedure and roadmap to make new medical products more readily available during health emergencies
2. WHO consultation on the Model List of essential in vitro diagnostics, the open session has been postponed.
We thank you for your interest in attending the Open Session of the Third meeting of the Strategic Advisory Group of Experts on in Vitro Diagnostics (SAGE IVD) on 23 March 2020 in Geneva.
Due to escalating health concerns relating to the coronavirus disease (COVID-19), the one-day open session has been postponed to a future date, which will be communicated to you.
The priority now is to have available diagnostics for COVID, protect the population and provide health services to patients, so the SAGE IVD is being postponed.
In the meanwhile, the SAGE IVD secretariat will be pleased to accept any comment, suggestion, and concerns from the public, regarding :
- Essential Diagnostic List and review of the submissions, until 23 March 2020, including: on the submissions for new test categories ( 26), submissions for negative listing (2) or for additional evidence for conditional listing on the 2nd EDL, to be discussed for the 3rd EDL. (5)
3. WHO Employment
Closing Date: Mar 16, 2020, Primary Location: Switzerland-Geneva, Organization: HQ/MHP Access to Medicines and Health Products:
- Director, Health Product Policy and Standards - (2000455)
- Director, Regulation, and Prequalification - (2000305)
- Link to: More employment postings
4. Subscribe to WHO Newsletter
In the link below you can register to the WHO general news
Please stay safe, wash your hands and take care!!
Adriana Velazquez Berumen, MSc. | Biomedical Engineer | Group Lead Medical Devices and In Vitro Diagnostics, MDD | Health Product Policy and Standards Department, HPS | Access to Medicines and Health Products Division, MHP | World Health Organization, WHO | Geneva, Switzerland
Content provided by IFMBE Clinical Engineering Division (IFMBE CED)
The International Federation for Medical and Biological Engineering (IFMBE) is the only international professional federation that has a Clinical Engineering Division focusing specifically on the life cycle management of healthcare technology and embracing all those who professionally practice in the clinical engineering field, whether in academic institutions, health care facilities, industry, business, voluntary sector, or government. For more information, please go to https://ced.ifmbe.org.